Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             335 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abnormal prorenin processing in growth hormone deficiency Gordon, Michael S.
 2005
 69-70 4 p. 251-255
5 p.
 artikel
2 Abstract index 1998
 69-70 4 p. 353-360
8 p.
 artikel
3 Abstracts 2002
 69-70 4 p. 223-307
85 p.
 artikel
4 A clinical trial of recombinant human growth hormone treatment of children with myelemingocele Rotenstein, D
 1998
 69-70 4 p. 342-
1 p.
 artikel
5 A comparision of three methods of assessing body composition in growth hormone-deficient adults Healy, ML
 1998
 69-70 4 p. 345-
1 p.
 artikel
6 A comparison of the growth hormone (GH) response to growth hormone-releasing hormone (GHRH), exercise and placebo in patients with type 2 diabetes mellitus Besser, REJ
 1998
 69-70 4 p. 352-
1 p.
 artikel
7 Acute changes of GH levels do not alter leptin serum levels in children and adolescents Bennek, C
 1998
 69-70 4 p. 351-352
2 p.
 artikel
8 Adaptation of the growth hormone binding protein LIFA for detection of growth hormone: Growth hormone binding protein complexes Chestnut, RE
 1998
 69-70 4 p. 334-
1 p.
 artikel
9 Aims & Scope/Editorial Board 2009
 69-70 4 p. i-
1 p.
 artikel
10 Aims & Scope/Editorial Board 2010
 69-70 4 p. i-
1 p.
 artikel
11 Aims & Scope/Editorial Board 2003
 69-70 4 p. i-
1 p.
 artikel
12 Aims & Scope/Editorial Board 2007
 69-70 4 p. i-
1 p.
 artikel
13 Aims & Scope/Editorial Board 2008
 69-70 4 p. i-
1 p.
 artikel
14 Aims & Scope/Editorial Board 2006
 69-70 4 p. i-
1 p.
 artikel
15 Aims & Scope/Editorial Board 2011
 69-70 4 p. i-
1 p.
 artikel
16 An analysis of IGFBP evolution Gordon, Phillip V.
 2008
 69-70 4 p. 284-290
7 p.
 artikel
17 Angiotensin II-induced reduction in body mass is Ang II receptor mediated in association with elevated corticosterone Ortiz, Rudy M.
 2010
 69-70 4 p. 282-288
7 p.
 artikel
18 An immunofunctional GH assay: Use in children Mauras, N
 1998
 69-70 4 p. 319-
1 p.
 artikel
19 A non-linear model for simulation of growth hormone kinetics Boroujerdi, MA
 1998
 69-70 4 p. 334-
1 p.
 artikel
20 A pharmacokinetic and pharmacodynamic study of NNC 26-0703 in Beagle dogs Nielsen, KK
 1998
 69-70 4 p. 332-
1 p.
 artikel
21 A purified bovine serum albumin preparation contains an insulin-like growth factor (IGF) binding protein-3 fragment that forms ternary complexes selectively with IGF-II and the acid-labile subunit Twigg, S.M
 2000
 69-70 4 p. 215-223
9 p.
 artikel
22 A role for plasmin in platelet aggregation: Differential regulation of IGF release from IGF–IGFBP complexes? Marcinkiewicz, Marek
 2008
 69-70 4 p. 325-334
10 p.
 artikel
23 A sport’s journalist’s view Goodbody, John
 2009
 69-70 4 p. 289-290
2 p.
 artikel
24 Association between growth hormone therapy and mortality, cancer and cardiovascular risk: Systematic review and meta-analysis Deodati, Annalisa
 2014
 69-70 4 p. 105-111
7 p.
 artikel
25 Association of polymorphism of the GH-1 gene with GH secretion Hasegawa, Y
 1998
 69-70 4 p. 329-
1 p.
 artikel
26 A study of the growth-promoting and metabolic effects of growth hormone (GH) in a patient with the “growth without GH” syndrome Pavlou, M.
 2001
 69-70 4 p. 225-230
6 p.
 artikel
27 Author Index 2002
 69-70 4 p. 313-322
10 p.
 artikel
28 Auxology-based cut-off values for biochemical testing of GH secretion in childhood Binder, G.
 2011
 69-70 4 p. 212-218
7 p.
 artikel
29 Baseline characteristics and diagnosis of GHD in adults with hypopituitarism Feldt-Rasmussen, U
 1998
 69-70 4 p. 344-
1 p.
 artikel
30 Baseline leptin and serum GH-binding-protein show a strong correlation in GH-deficient adults Barnard, R
 1998
 69-70 4 p. 325-
1 p.
 artikel
31 Beneficial effect of growth hormone (GH) replacement therapy on serum slalic acid levels in adult patients with GH-deficiency Christ, ER
 1998
 69-70 4 p. 323-
1 p.
 artikel
32 Biological effects in rats of NNC 26-0703, a new oral growth hormone secretagogue Johansen, PB
 1998
 69-70 4 p. 331-
1 p.
 artikel
33 Body size, IGF and growth hormone polymorphisms, and colorectal adenomas and hyperplastic polyps Wernli, Karen J.
 2010
 69-70 4 p. 305-309
5 p.
 artikel
34 Bone markers and growth hormone (GH) abuse in athletes Wallace, JD
 1998
 69-70 4 p. 348-
1 p.
 artikel
35 Brief, high intensity exercise alters serum ghrelin and growth hormone concentrations but not IGF-I, IGF-II or IGF-I bioactivity Stokes, Keith A.
 2010
 69-70 4 p. 289-294
6 p.
 artikel
36 Case report: Low circulating IGF-I levels due to Acid-Labile Subunit deficiency in adulthood are not associated with early development of atherosclerosis and impaired heart function Rensing, K.L.
 2011
 69-70 4 p. 233-237
5 p.
 artikel
37 Changes in body composition, body fat distribution, and energy expenditure in growth hormone deficient children on growth hormone therapy Roemmich, JN
 1998
 69-70 4 p. 341-342
2 p.
 artikel
38 Changes in body mass index in girls with turner syndrome Blackett, PR
 1998
 69-70 4 p. 343-
1 p.
 artikel
39 Changes in insulin sensitivity induced by short-term growth hormone (GH) and insulin-like growth factor I (IGF-I) treatment in GH-deficient adults are not associated with changes in adiponectin levels Schmid, Christoph
 2005
 69-70 4 p. 300-303
4 p.
 artikel
40 Changes in lipoprotein (a) levels measured by six kit methods during growth hormone treatment of growth hormone deficient adults Laron, Zvi
 2000
 69-70 4 p. 230-231
2 p.
 artikel
41 Changes in lipoprotein (a) levels measured by six kit methods during growth hormone treatment of growth hormone deficient adults Wieringa, G.
 2000
 69-70 4 p. 231-
1 p.
 artikel
42 Changes in total ghrelin within the somatotropic axis in severe burn patients: Comparison of those with inhalation injury and those without inhalation injury Lee, B.W.
 2008
 69-70 4 p. 291-297
7 p.
 artikel
43 Characterisation of receptors for IGF-I and insulin; evidence for hybrid insulin/IGF-I receptor in human coronary artery endothelial cells Chisalita, Simona I.
 2006
 69-70 4 p. 258-266
9 p.
 artikel
44 Characterization of binding sites involved in the inhibitory action of amylin and calcitonin on GH release in the rat Sibilia, V
 1998
 69-70 4 p. 334-
1 p.
 artikel
45 Characterization of GH secretory ability of GH deficient children: Response to MK-0677 Yu, H
 1998
 69-70 4 p. 332-333
2 p.
 artikel
46 Characterization of rat growth hormone binding protein (GHBP) isoforms Ymer, SI
 1998
 69-70 4 p. 336-
1 p.
 artikel
47 Chronic intracerebroventricular TLQP-21 delivery does not modulate the GH/IGF-1-axis and muscle strength in mice Bartolomucci, A.
 2007
 69-70 4 p. 342-345
4 p.
 artikel
48 CIDE-A gene expression is decreased in white adipose tissue of growth hormone receptor/binding protein gene disrupted mice and with high-fat feeding of normal mice Kelder, Bruce
 2007
 69-70 4 p. 346-351
6 p.
 artikel
49 Circulating IGF-axis protein levels and their relation with levels of plasma adipocytokines and macronutrient consumption in women Beasley, Jeannette M.
 2014
 69-70 4 p. 142-149
8 p.
 artikel
50 Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia Fukuda, Izumi
 2006
 69-70 4 p. 211-216
6 p.
 artikel
51 Cloning and characterization of new transcript variants of insulin-like growth factor-I in Sika deer (Cervus elaphus) Zhang, Jinyu
 2013
 69-70 4 p. 120-127
8 p.
 artikel
52 Coevolution of insulin-like growth factors, insulin and their receptors and binding proteins in New World Monkeys Wallis, Michael
 2015
 69-70 4 p. 158-167
10 p.
 artikel
53 Committee 1998
 69-70 4 p. 305-
1 p.
 artikel
54 Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients Fideleff, H.L.
 2008
 69-70 4 p. 318-324
7 p.
 artikel
55 Comparing adiposity profiles in three mouse models with altered GH signaling Berryman, Darlene E
 2004
 69-70 4 p. 309-318
10 p.
 artikel
56 Comparison between IGF-I and GH in perinatal growth Laron, Z
 1998
 69-70 4 p. 319-
1 p.
 artikel
57 Comparison of the somatogenic action of 20kDa- and 22kDa-human growth hormones in spontaneous dwarf rats Ishikawa, M.
 2000
 69-70 4 p. 199-206
8 p.
 artikel
58 Contiguous amino-acid substitutions in the extracellular domain of the growth hormone receptor, identified in patients with laron syndrome, differently affect receptor binding affinity and membrane expression Postel-Vinay, MC
 1998
 69-70 4 p. 321-
1 p.
 artikel
59 Continuation of GH treatment for growth hormone deficiency after adolescence Shalet, S
 1998
 69-70 4 p. 312-
1 p.
 artikel
60 Control of cell survival by IGF signaling pathways Vincent, Andrea M
 2002
 69-70 4 p. 193-197
5 p.
 artikel
61 Corneal thickness in children with growth hormone deficiency: The effect of GH treatment Ciresi, A.
 2014
 69-70 4 p. 150-154
5 p.
 artikel
62 Current concepts in the biochemical assessment of the patient with acromegaly Freda, Pamela U.
 2003
 69-70 4 p. 171-184
14 p.
 artikel
63 Demographic factors influencing the GH system: Implications for the detection of GH doping in sport Nelson, Anne E.
 2009
 69-70 4 p. 327-332
6 p.
 artikel
64 Detection of GH abuse in sport: Past, present and future Barroso, Osquel
 2009
 69-70 4 p. 369-374
6 p.
 artikel
65 Detection of growth hormone abuse in athletes Wallace, JD
 1998
 69-70 4 p. 329-
1 p.
 artikel
66 Detection of growth hormone abuse in athletes Wallace, JD
 1998
 69-70 4 p. 347-348
2 p.
 artikel
67 Detection of growth hormone responsive proteins using SELDI–TOF mass spectrometry Chung, L.
 2009
 69-70 4 p. 383-387
5 p.
 artikel
68 Determinants of IGF-I in adult turner syndrome: The influence of sex hormones and GH Gravholt, CH
 1998
 69-70 4 p. 338-
1 p.
 artikel
69 Determination of free insulin-like growth factor-I in human serum: Comparison of ultra-filtration vs direct immunoradiometric assay Frystyk, J
 1998
 69-70 4 p. 337-
1 p.
 artikel
70 Developmental changes in the relationship between IGF-I and body composition during puberty Beckett, Philip R.
 1998
 69-70 4 p. 283-288
6 p.
 artikel
71 Diagnosing growth hormone deficiency in adults with hypothalamic-pituitary disease Hoeck, HC
 1998
 69-70 4 p. 323-
1 p.
 artikel
72 Diagnosis of adult GH deficiency (GHD): Predictive value of serum IGF-I and number of pituitary hormone deficits Hartman, ML
 1998
 69-70 4 p. 344-
1 p.
 artikel
73 Diagnostic discriminatory capacity of three different approaches to the measurement of the acid-labile subunit (ALS) Morrison, KM
 1998
 69-70 4 p. 316-
1 p.
 artikel
74 Differences in the effects of 20K- and 22K-hGH on water retention in rats Satozawa, N.
 2000
 69-70 4 p. 187-192
6 p.
 artikel
75 Differential amplification of the pulsatile, nycothemeral and entropic modes of GH secretion by estradiol (E2) or GHRP-2 or both in concert in post-menopausal women Shah, N
 1998
 69-70 4 p. 314-
1 p.
 artikel
76 Differential changes in free and total insulin-like growth factor-I after major, elective abdominal surgery: The possible role of insulin-like growth factor binding protein-3 proteolysis Skjaerbaek, C
 1998
 69-70 4 p. 338-
1 p.
 artikel
77 Differential effect of growth hormone on cortical and cancellous bone formation in glucocorticoid injected young rats Ortoft, GO
 1998
 69-70 4 p. 328-
1 p.
 artikel
78 Differential effects on kidney and liver growth of a non-viral hGH-expression vector in hypophysectomized mice Khamaisi, Mogher
 2007
 69-70 4 p. 279-287
9 p.
 artikel
79 Differential gene expression induced by growth hormone treatment in the uremic rat growth plate Gil, Helena
 2008
 69-70 4 p. 353-359
7 p.
 artikel
80 Differential interactions of insulin-like growth factor binding proteins (1–6) with the ceramide-induced apoptotic signalling pathway in an IGF-independent manner Perks, CM
 1998
 69-70 4 p. 339-
1 p.
 artikel
81 Dimensions, densities and mechanical strength of bones from aged growth hormone-transgenic mice Andreassen, TT
 1998
 69-70 4 p. 322-323
2 p.
 artikel
82 Discontinuation of GH treatment in adolescent patients: Effects on bone mass Johannsson, Gudmundur
 1998
 69-70 4 p. 324-
1 p.
 artikel
83 Discontinuation of GH treatment in adolescent patients: Effects on bone mass Johannsson, Gudmundur
 1998
 69-70 4 p. 344-
1 p.
 artikel
84 Discontinuation of GH treatment in adolescent patients: Effects on quality of life and psychological well-being Wirén, Lena
 1998
 69-70 4 p. 330-
1 p.
 artikel
85 Discontinuation of GH treatment in adolescent patients: Metabolic effects Johannsson, G
 1998
 69-70 4 p. 343-344
2 p.
 artikel
86 Does clinical status correlate with the severity of GH deficiency (GHD) in adults? Colao, A
 1998
 69-70 4 p. 316-317
2 p.
 artikel
87 Does growth hormone replacement therapy result in recurrence of increase in the size of pituitary tumours? Hatrick, AG
 1998
 69-70 4 p. 318-
1 p.
 artikel
88 Dose-specific or dose-dependent effect of growth hormone treatment on the proliferation and differentiation of cultured neuronal cells Lyuh, Esther
 2007
 69-70 4 p. 315-322
8 p.
 artikel
89 Editorial Board 2014
 69-70 4 p. i-
1 p.
 artikel
90 Editorial Board 2002
 69-70 4 p. i-
1 p.
 artikel
91 Editorial board 2005
 69-70 4 p. i-
1 p.
 artikel
92 Editorial board 2004
 69-70 4 p. i-
1 p.
 artikel
93 Editorial Board 2015
 69-70 4 p. i-
1 p.
 artikel
94 Editorial Board 2013
 69-70 4 p. i-
1 p.
 artikel
95 Effect of a long-acting growth hormone receptor antagonist on renal enlargement, glomerular hypertrophy and urinary albumin excretion (UAE) in experimental diabetes Flyvbjerg, Allan
 1998
 69-70 4 p. 326-
1 p.
 artikel
96 Effect of a sleep debt on the 24-H growth hormone profile in humans L'Hermite-Baleriaux, M
 1998
 69-70 4 p. 348-
1 p.
 artikel
97 Effect of GHRH on LH-stimulated progestin in rat ovarian granulosa cells Usuki, Satoshi
 1998
 69-70 4 p. 330-
1 p.
 artikel
98 Effect of GH-treatment on bone mineral status in GHD-patients: Gender differences Rosén, T
 1998
 69-70 4 p. 349-
1 p.
 artikel
99 Effect of growth hormone deficiency on physical work capacity in patients with non-insulin-dependent diabetes mellitus and excessive body weight Davydov, A
 1998
 69-70 4 p. 352-
1 p.
 artikel
100 Effect of IGFBP-derived peptides on incorporation of35SO4into proteoglycans Booth, B.A.
 2000
 69-70 4 p. 224-229
6 p.
 artikel
101 Effect of IGFBP-3 on IGF- and IGF-analogue-induced insulin-like growth factor-I receptor (IGFIR) signalling Devi, Gayathri R.
 2001
 69-70 4 p. 231-239
9 p.
 artikel
102 Effect of short-term IGF-I administration on sperm motility and seminal plasma IGF-I in young healthy males Ovesen, P
 1998
 69-70 4 p. 337-
1 p.
 artikel
103 Effect of the GHRP-6 analog hexarelin and arginine alone and combined on GH secretion in patients with active acromegaly Mascadri, C
 1998
 69-70 4 p. 331-
1 p.
 artikel
104 Effect of topical application of raspberry ketone on dermal production of insulin-like growth factor-I in mice and on hair growth and skin elasticity in humans Harada, Naoaki
 2008
 69-70 4 p. 335-344
10 p.
 artikel
105 Effects of acute IGF-I and IGFBP3 on myocardial contractility: Studies in rat and ferret isolated muscle Cittadini, A
 1998
 69-70 4 p. 316-
1 p.
 artikel
106 Effects of early treatment with growth hormone on infarct size, survival, and cardiac gene expression after acute myocardial infarction Jin, Hongkui
 2002
 69-70 4 p. 208-215
8 p.
 artikel
107 Effects of fasting, refeeding and systemic growth hormone on the GHRP-6 induction of fos protein in the rat arcuate nucleus Dickson, SL
 1998
 69-70 4 p. 313-
1 p.
 artikel
108 Effects of GH and IGF-I in cultured rat ovarian granulosa cells Usuki, S
 1998
 69-70 4 p. 336-
1 p.
 artikel
109 Effects of GH on protein metabolism during dietary restriction in man Nørrelund, Helene
 2002
 69-70 4 p. 198-207
10 p.
 artikel
110 Effects of graded treatment with GHRH(1-29)NH2 in older women Hirth, V
 1998
 69-70 4 p. 330-
1 p.
 artikel
111 Effects of hGH replacement on cerebral metabolism in adults with growth hormone deficiency Cranston, IC
 1998
 69-70 4 p. 317-318
2 p.
 artikel
112 Effects of IGF-1, TGF-α plus TGF-β1 and bFGF on in vitro survival, growth and apoptosis in FSH-stimulated buffalo (Bubalis bubalus) preantral follicles Sharma, G. Taru
 2010
 69-70 4 p. 319-325
7 p.
 artikel
113 Effects of ipamorelin — A growth hormone secretagogue-on bone formation and skeletal muscle contraction force Andersen, NB
 1998
 69-70 4 p. 313-
1 p.
 artikel
114 Effects of levothyroxine on growth hormone (gh) sensitivity in children with idiopathic short stature García, Roberto J.
 2014
 69-70 4 p. 119-122
4 p.
 artikel
115 Effects of pure ethanol and alcopops on glucose, insulin, and the insulin-like growth factor system in healthy subjects Grønbæk, H.
 2005
 69-70 4 p. 243-250
8 p.
 artikel
116 Effects of recombinant mouse growth hormone treatment on growth and body composition in GHRH knock out mice Alba, Maria
 2005
 69-70 4 p. 275-282
8 p.
 artikel
117 Effects of testosterone either alone or with IGF-I on growth of cells derived from the proliferation zone of regenerating antlers in vitro Sadighi, M.
 2001
 69-70 4 p. 240-246
7 p.
 artikel
118 Effects of 1 year treatment with GH in an old patient with chronic congestive heart failure and GHD Ceda, GP
 1998
 69-70 4 p. 350-
1 p.
 artikel
119 Efficacy of, and individual susceptibility to, GH-replacement in adults Monson, JP
 1998
 69-70 4 p. 346-
1 p.
 artikel
120 Elderly patients with pituitary insufficiency benefit from growth hormone replacement therapy Thorén, M
 1998
 69-70 4 p. 347-
1 p.
 artikel
121 Elevated serum IGF-I is associated with an increased risk of colorectal neoplasia in acromegaly Jenkins, PJ
 1998
 69-70 4 p. 351-
1 p.
 artikel
122 Enhancement of growth hormone gene expression in the pituitary and brain by acanthopanax senticosus harms Yoshizato, H
 1998
 69-70 4 p. 327-
1 p.
 artikel
123 Erratum to: “Novel actions of IGFBP-3 on intracellular signaling pathways of insulin-secreting cells” [Growth Horm. IGF Res. 16 (1) (2006) 41–48] Chen, Xiaoyan
 2006
 69-70 4 p. 276-
1 p.
 artikel
124 Evaluation of the outcome of neurosurgical treatment of acromegaly: Relationship between IGF-I and growth hormone at baseline and after oral glucose tolerance test (OGTT) levels Doga, M
 1998
 69-70 4 p. 350-
1 p.
 artikel
125 Expression levels of insulin-like growth factors 1 and 2 in head and neck squamous cell carcinoma Zhi, Xu
 2014
 69-70 4 p. 137-141
5 p.
 artikel
126 Expression of insulin-like growth factor 1 isoforms in the rabbit oculomotor system Feng, Cheng-Yuan
 2011
 69-70 4 p. 228-232
5 p.
 artikel
127 Expression of novel growth hormone receptor (GHR) transcripts in human heart tissue Schwartzbauer, G
 1998
 69-70 4 p. 328-
1 p.
 artikel
128 Final height after combined growth hormone and gonadotropin-releasing hormone analog therapy in short healthy children entering into normally time puberty Lanes, R
 1998
 69-70 4 p. 342-
1 p.
 artikel
129 Free insulin-like growth factor-I and-II in obesity, niddm and IDDM Orskov, H
 1998
 69-70 4 p. 315-
1 p.
 artikel
130 Frequency of the MSTN Lys(K)-153Arg(R) polymorphism among track & field athletes and swimmers Ben-Zaken, Sigal
 2015
 69-70 4 p. 196-200
5 p.
 artikel
131 Gender differences in sensitivity to short-term administration of growth hormone (GH) in healthy young adults Edén Engström, B
 1998
 69-70 4 p. 347-
1 p.
 artikel
132 Gender-specific dose-responses to GH in GHD children: Results of a 3-year randomized trial in 109 patients Cohen, P
 1998
 69-70 4 p. 320-
1 p.
 artikel
133 Genetic defects in the growth hormone/insulin-like growth factors axis Chihara, Kazuo
 1998
 69-70 4 p. 312-
1 p.
 artikel
134 Gene transcription of receptors for growth hormone releasing peptides and somatostatin in human pituitary adenomas Nielsen, S
 1998
 69-70 4 p. 321-
1 p.
 artikel
135 GH & IGF Research issue on doping with growth hormone Sönksen, Peter H.
 2009
 69-70 4 p. 283-284
2 p.
 artikel
136 GHRP-2 + TRH infusion for 5 days during protracted critical illness: Endocrine and metabolic effects Van den Berghe, G
 1998
 69-70 4 p. 312-
1 p.
 artikel
137 GH secretion after pharmacological tests (GHRH, clonidine and GHRH+pyridostigmine) both in GH deficient patients and severe obesity Orio Jr, F
 1998
 69-70 4 p. 345-
1 p.
 artikel
138 GH secretion in obese children after hypocaloric diet Sgattoni, C
 1998
 69-70 4 p. 340-
1 p.
 artikel
139 GH-therapy of a child with short bowel syndrome: A case history about the influence of GH on short-term growth, growth factors and intestinal villi Keller, A
 1998
 69-70 4 p. 342-343
2 p.
 artikel
140 GH treatment of childhood-onset adult GH deficiency: Results of a 2-year placebocontrolled trial Underwood, LE
 1998
 69-70 4 p. 317-
1 p.
 artikel
141 Granulosa cell proliferation is impaired in the Igf1 null ovary Kadakia, Reepa
 2001
 69-70 4 p. 220-224
5 p.
 artikel
142 Growth, development, puberty and adult height before and during treatment in children with congenital isolated growth hormone deficiency Smuel, Keren
 2015
 69-70 4 p. 182-188
7 p.
 artikel
143 Growth hormone administration conserves nitrogen and accelerates lipolysis during dietary restriction in obese subjects Noorrelund, H
 1998
 69-70 4 p. 323-324
2 p.
 artikel
144 Growth hormone and cognitive function in healthy older men Aleman, A
 1998
 69-70 4 p. 329-
1 p.
 artikel
145 Growth hormone and faconi anemia Doerr, HG
 1998
 69-70 4 p. 343-
1 p.
 artikel
146 Growth hormone and heart failure: Oxidative stress and energetic metabolism in rats Seiva, F.R.F.
 2008
 69-70 4 p. 275-283
9 p.
 artikel
147 Growth hormone and the adolescent athlete: What are the data for its safety and efficacy as an ergogenic agent? Rogol, Alan D.
 2009
 69-70 4 p. 294-299
6 p.
 artikel
148 Growth hormone axis-independent growth Hathout, EH
 1998
 69-70 4 p. 340-
1 p.
 artikel
149 Growth hormone decreases hepatic amino acid degradation after major surgery in rats Ljungmann, K
 1998
 69-70 4 p. 335-
1 p.
 artikel
150 Growth hormone enhances expression and DNA binding activity of CCAAT/enhancer binding protein-β (C/EBPα) in primary cultures of rat hepatocytes Jansson, J-O
 1998
 69-70 4 p. 321-
1 p.
 artikel
151 Growth hormone (GH) rebound response after somatostatin (SRIH) withdrawal is blunted in human obesity Ambrosio, MR
 1998
 69-70 4 p. 331-
1 p.
 artikel
152 Growth hormone (GH) status following cure of cushing's disease Hughes, NR
 1998
 69-70 4 p. 317-
1 p.
 artikel
153 Growth hormone increases VLDL apolipoprotein B100 secretion and clearance rate Christ, ER
 1998
 69-70 4 p. 326-
1 p.
 artikel
154 Growth hormone induces a substantial turnover of lung collagens in old rats Oxlund, H.
 1998
 69-70 4 p. 335-
1 p.
 artikel
155 Growth hormone isoforms Baumann, Gerhard P.
 2009
 69-70 4 p. 333-340
8 p.
 artikel
156 Growth hormone receptor-dependent expression of IGFBP-4 mRNA in chicken liver Tanaka, M
 1998
 69-70 4 p. 338-339
2 p.
 artikel
157 Growth hormone replacement in adults with GH deficiency—the first 10 years Sonksen, Peter H
 1998
 69-70 4 p. 275-276
2 p.
 artikel
158 Growth hormone replacement therapy increases handgrip strength in 21 growth hormone-deficient adults Tschöp, M
 1998
 69-70 4 p. 348-
1 p.
 artikel
159 Growth hormone resistant states: Pathophysiology and treatment Underwood, Louis
 1998
 69-70 4 p. 311-312
2 p.
 artikel
160 Growth hormone response to low-dose apomorphine in restless legs syndrome Happe, Svenja
 2007
 69-70 4 p. 323-327
5 p.
 artikel
161 Growth hormone secretagogue ipamorelin reduces the hepatic catabolic stress response during steroid treatment Grofte, T
 1998
 69-70 4 p. 312-313
2 p.
 artikel
162 Growth hormone signalling and its regulation: Preventing too much of a good thing Frank, Stuart J.
 2001
 69-70 4 p. 201-212
12 p.
 artikel
163 Growth hormone signal transduction Carter-Su, Christin
 1998
 69-70 4 p. 311-
1 p.
 artikel
164 Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome Sode-Carlsen, Rasmus
 2011
 69-70 4 p. 185-190
6 p.
 artikel
165 Heart structure and function in dwarf rats in vivo before and after GH replacement: Echocardiographic evaluation Cittadini, A
 1998
 69-70 4 p. 328-
1 p.
 artikel
166 Hemostatic variables in patients with GH excess or deficiency Sartorio, A
 1998
 69-70 4 p. 350-
1 p.
 artikel
167 Hepatocyte-stimulated expression of hepatocyte growth factor (HGF) in cultured rat hepatic stellate cells Jansson, J-O
 1998
 69-70 4 p. 315-316
2 p.
 artikel
168 Hexarelin, a growth hormone – releasing peptide, counteracts bone loss in gonadectomized male rats Sibilia, V.
 1999
 69-70 4 p. 219-227
9 p.
 artikel
169 Hexarelin improves heart function in rats after experimental myocardial infarction without an increase in cardiac IGF-I mRNA Tivesten, A
 1998
 69-70 4 p. 331-
1 p.
 artikel
170 HGH – The perspective of an elite rower and journalist Pinsent, Matthew
 2009
 69-70 4 p. 288-
1 p.
 artikel
171 Human growth hormone: 45-kDa isoform with extraordinarily stable interchain disulfide links has attenuated receptor-binding and cell-proliferative activities Bustamante, Juan J.
 2010
 69-70 4 p. 298-304
7 p.
 artikel
172 Human thymic cells produce GH and express GH receptors Postel-Vinay, MC
 1998
 69-70 4 p. 334-
1 p.
 artikel
173 Identification of a serum factor that binds and alters the GH binding properties of rat GH-binding protein Leung, KC
 1998
 69-70 4 p. 327-328
2 p.
 artikel
174 IGFBP2000 Abstracts 2000
 69-70 4 p. 233-273
41 p.
 artikel
175 IGF2BP1, IGF2BP2 and IGF2BP3 genotype, haplotype and genetic model studies in metabolic syndrome traits and diabetes Rodriguez, S.
 2010
 69-70 4 p. 310-318
9 p.
 artikel
176 IGF-I abuse in sport: Current knowledge and future prospects for detection Guha, Nishan
 2009
 69-70 4 p. 408-411
4 p.
 artikel
177 IGF-I and GH: Potential use in gene doping Harridge, Stephen D.R.
 2009
 69-70 4 p. 378-382
5 p.
 artikel
178 IGF-I and IGFBP-3 in healthy 9month old infants from the SKOT cohort: Breastfeeding, diet, and later obesity Madsen, Anja L.
 2011
 69-70 4 p. 199-204
6 p.
 artikel
179 IGF-I binding to the IGF-I receptor is affected by contaminants in commercial BSA: The contaminants are proteins with IGF-I binding properties Slaaby, Rita
 2008
 69-70 4 p. 267-274
8 p.
 artikel
180 IGF-I but not an IGF-I analog increases serum IGF binding protein-3 (IGFBP-3) in adolescent female monkeys Wilson, ME
 1998
 69-70 4 p. 315-
1 p.
 artikel
181 IGF-IEc expression, regulation and biological function in different tissues Dai, Zhongquan
 2010
 69-70 4 p. 275-281
7 p.
 artikel
182 IGF-I expression is downregulated in hypertrophic growth-plate chondrocytes in vivo but not in vitro Olney, RC
 1998
 69-70 4 p. 336-337
2 p.
 artikel
183 IGF-I generation test: Effects on body composition Longobardi, S
 1998
 69-70 4 p. 340-
1 p.
 artikel
184 IGF-I–IGFBP-3–acid-labile subunit (ALS) complex in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH) Völkl, Thomas M.K.
 2011
 69-70 4 p. 191-198
8 p.
 artikel
185 IGF-I protects human oral buccal mucosal epithelial cells from sodium nitroprusside-induced apoptosis via PI3-kinase Brady, Garrett
 2008
 69-70 4 p. 298-306
9 p.
 artikel
186 IGF-I response to short-term administration of low RHGH dose as function of sex, age and pathophysiological conditions Arvat, E
 1998
 69-70 4 p. 337-338
2 p.
 artikel
187 IGF-I treatment increases motility and improves morphology of immature spermatozoa in the GH-deficient dwarf (dw/dw) rat Vickers, M.H.
 1999
 69-70 4 p. 236-240
5 p.
 artikel
188 IGF-I variability during GHRH treatment: Effect of diet control Merriam, GR
 1998
 69-70 4 p. 330-
1 p.
 artikel
189 IGFs and aging: is there a rationale for hormone replacement therapy? Hoffman, Andrew R
 2004
 69-70 4 p. 296-300
5 p.
 artikel
190 Immunolocalization of insulin-like growth factor I (IGF-I) during preimplantation in rat uterus Öner, Jale
 2007
 69-70 4 p. 271-278
8 p.
 artikel
191 Increased class A scavenger receptor and glomerular lipid precede mesangial matrix expansion in the bGH mouse model Doi, Sonia Q.
 2010
 69-70 4 p. 326-332
7 p.
 artikel
192 Increased disorderliness and decreased mass and daily rate of endogenous growth hormone secretion in adult turner syndrome: the impact of body composition, maximal oxygen uptake and treatment with sex hormones Gravholt, Claus Højbjerg
 1998
 69-70 4 p. 289-298
10 p.
 artikel
193 Increased gene expression of a truncated growth hormone (GH) receptor relative to the full-length receptor after 4 months of GH substitution in GH deficient adults Fisker, S
 1998
 69-70 4 p. 323-
1 p.
 artikel
194 Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases Gibson, Tara Leigh Beers
 1999
 69-70 4 p. 241-253
13 p.
 artikel
195 Influence of a single course of antenatal betamethasone on the maternal–fetal insulin-IGF-GH axis in singleton pregnancies Ahmad, Irfan
 2006
 69-70 4 p. 267-275
9 p.
 artikel
196 Insulin-like growth factor binding protein-4 accumulation is negatively correlated with growth rate in TM-3 cells Hasegawa, Tomonobu
 1998
 69-70 4 p. 277-282
6 p.
 artikel
197 Insulin-like growth factor binding protein-2 (IGFBP-2) levels are elevated in patients with acromegaly and colonic neoplasia Miraki-Moud, F
 1998
 69-70 4 p. 351-
1 p.
 artikel
198 Insulin-like growth factor binding protein (IGFBP) signalling Ricort, Jean-Marc
 2004
 69-70 4 p. 277-286
10 p.
 artikel
199 Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator Juncker-Jensen, A.
 2006
 69-70 4 p. 224-239
16 p.
 artikel
200 Insulin-like growth factor-I and cancer risk Ibrahim, Yasir H
 2004
 69-70 4 p. 261-269
9 p.
 artikel
201 Insulin-like Growth Factor I and its binding protein 3 in sepsis Papastathi, Chrysoula
 2013
 69-70 4 p. 98-104
7 p.
 artikel
202 Insulin like growth factor I (IGF-1) administration induces fluid and sodium retention in healthy adults Mooller, J
 1998
 69-70 4 p. 324-325
2 p.
 artikel
203 Insulin-like growth factor-1 stimulates vascular smooth muscle cell proliferation in rat aorta in vivo Chen, Y.
 1998
 69-70 4 p. 299-303
5 p.
 artikel
204 Insulin requirements decrease after 2 weeks of subcutaneous administration of B2036-PEG (Trovert-tm), a growth hormone antagonist, to type I diabetics Schwartz, SL
 1998
 69-70 4 p. 352-
1 p.
 artikel
205 Intramuscular administration of PEGylated IGF-I improves skeletal muscle regeneration after myotoxic injury Martins, Karen J.B.
 2013
 69-70 4 p. 128-133
6 p.
 artikel
206 Intrinsic cardiac muscle function, calcium handling and β -adrenergic responsiveness is impaired in rats with growth hormone deficiency Strömer, Hinrik
 1999
 69-70 4 p. 262-271
10 p.
 artikel
207 Investigation of IGF2/ApaI and H19/RsaI polymorphisms in patients with cutaneous melanoma Soares, M.R.
 2010
 69-70 4 p. 295-297
3 p.
 artikel
208 Investigation of IGF2, Hedgehog and fusion gene expression profiles in pediatric sarcomas de Souza, Robson Ramos
 2014
 69-70 4 p. 130-136
7 p.
 artikel
209 Involvement of mitogen-activated protein kinase (MAPK and the insulin-like growth factor-i receptor (IGF-IR) in apoptosis Stewart, CEH
 1998
 69-70 4 p. 333-
1 p.
 artikel
210 Ipamorelin — A novel very potent growth hormone secretagogue Rasmussen, MH
 1998
 69-70 4 p. 332-
1 p.
 artikel
211 Islet insulin content and release are increased in male mice with elevated endogenous GH and IGF-I, without evidence of systemic insulin resistance or alterations in β-cell mass Cordoba-Chacon, Jose
 2015
 69-70 4 p. 189-195
7 p.
 artikel
212 Keywords Index 2002
 69-70 4 p. 309-312
4 p.
 artikel
213 20K-GH and its use in detecting GH abuse Irie, Minoru
 2009
 69-70 4 p. 352-356
5 p.
 artikel
214 20K GH isoforms in small for gestational age infants Chasalow, FI
 1998
 69-70 4 p. 341-
1 p.
 artikel
215 20-Kilodalton(KDA) human growth hormone in human pituitaries and GH-secreting pituitary adenomas Sanno, N
 1998
 69-70 4 p. 336-
1 p.
 artikel
216 Laboratory issues in the implementation of the marker method Cowan, David A.
 2009
 69-70 4 p. 357-360
4 p.
 artikel
217 L-agrinine-induced growth hormone secretion is not influenced by co-infusion of the no synthase inhibitior N-monomethyl-L-arginine in healthy men Fisker, S
 1998
 69-70 4 p. 345-
1 p.
 artikel
218 Land of the giants Sharp, R.J.
 2009
 69-70 4 p. 291-293
3 p.
 artikel
219 Leptin levels and GH dynamics in obesity: Variations after biliopancreatic diversion De Marinis, L
 1998
 69-70 4 p. 325-326
2 p.
 artikel
220 Leptin levels in protracted critical illness: Effects of GH-secretagogues and TRH Van den Berghe, G
 1998
 69-70 4 p. 326-
1 p.
 artikel
221 Lipolysis stimulation by 20 K hGH in 3T3-L1-hGHR Asada, N
 1998
 69-70 4 p. 336-
1 p.
 artikel
222 Local changes in the insulin-like growth factor system in human skeletal muscle assessed by microdialysis and arterio-venous differences technique Berg, U.
 2006
 69-70 4 p. 217-223
7 p.
 artikel
223 Local IGF-I expression and bone formation McCarthy, Thomas L.
 2001
 69-70 4 p. 213-219
7 p.
 artikel
224 Longitudinal changes in growth hormone release, body composition, and body fat distribution are inversely related in children and adolescents Roemmich, JN
 1998
 69-70 4 p. 319-
1 p.
 artikel
225 Long-term safeety during growth hormone (GH) treatment of GH-deficient adults: A one-center study Bengtsson, B-A
 1998
 69-70 4 p. 318-
1 p.
 artikel
226 Long-term safety during growth hormone (GH) treatment of GH-deficient adults: A one-center study Bengtsson, B-A
 1998
 69-70 4 p. 347-
1 p.
 artikel
227 Long-term treatment outcome in acromegaly Holdaway, I.M
 2003
 69-70 4 p. 185-192
8 p.
 artikel
228 Maternal nutrient restriction during early to mid gestation up-regulates cardiac insulin-like growth factor (IGF) receptors associated with enlarged ventricular size in fetal sheep Dong, Feng
 2005
 69-70 4 p. 291-299
9 p.
 artikel
229 Maximum anaerobic performance of childhood-onset GH-deficient adults Narici, Marco
 1999
 69-70 4 p. 228-235
8 p.
 artikel
230 Measurement of serum 20K-hGH in children Ishikawa, M
 1998
 69-70 4 p. 319-
1 p.
 artikel
231 Meeting plan 2002
 69-70 4 p. 217-221
5 p.
 artikel
232 Metabolic alterations in patients who develop traumatic brain injury (TBI)-induced hypopituitarism Prodam, F.
 2013
 69-70 4 p. 109-113
5 p.
 artikel
233 Methylprednisolone does not inhibit the release of growth hormone after intravenous injection of a novel growth hormone secretagogue in rats Malmlof, K
 1998
 69-70 4 p. 332-
1 p.
 artikel
234 Monitoring response to growth hormone replacement-an ideal model Simpson, HL
 1998
 69-70 4 p. 346-
1 p.
 artikel
235 Moving one step closer to catching the GH cheats: The GH-2004 experience Holt, Richard I.G.
 2009
 69-70 4 p. 346-351
6 p.
 artikel
236 New concepts: growth hormone, insulin-like growth factor-I and the kidney Rabkin, Ralph
 2004
 69-70 4 p. 270-276
7 p.
 artikel
237 New developments in the neuroendocrine control of GH: Lessons from GH secretagogues Bach, MA
 1998
 69-70 4 p. 311-
1 p.
 artikel
238 NNC 26-0703, an orally active specific growth hormone secretagogue Raun, K
 1998
 69-70 4 p. 314-
1 p.
 artikel
239 No acute effect of insulin on insulin-like growth factor binding protein 3 (IGFBP-3) proteolysis in healthy subjects Flyvbjerg, A
 1998
 69-70 4 p. 338-
1 p.
 artikel
240 Normal growth despite GH, IGF-I and IGF-II deficiency Hathout, E.H
 1999
 69-70 4 p. 272-277
6 p.
 artikel
241 Novel compound heterozygous mutations of the growth hormone-releasing hormone receptor gene in a case of isolated growth hormone deficiency Soneda, Akiko
 2013
 69-70 4 p. 89-97
9 p.
 artikel
242 NT-proBNP, IGF-I and survival in patients with chronic heart failure Petretta, Mario
 2007
 69-70 4 p. 288-296
9 p.
 artikel
243 Nuclear translocation of transcription factor MSY-1 plays a role in pregnancy-specific expression of the GH receptor (GHR) gene Menon, RK
 1998
 69-70 4 p. 322-
1 p.
 artikel
244 Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults Drake, WM
 1998
 69-70 4 p. 346-
1 p.
 artikel
245 Over-expression of IGF-related peptides in stenoses of native arteriovenous fistulas in hemodialysis patients Stracke, Sylvia
 2007
 69-70 4 p. 297-306
10 p.
 artikel
246 Overview of the legal framework applicable to the marker method for the detection of human growth hormone Young, Richard R.
 2009
 69-70 4 p. 366-368
3 p.
 artikel
247 Pegvisomant bioavailability of single 30mg/mL subcutaneous injection compared to two 15mg/mL subcutaneous injections: A pharmacokinetic, safety and tolerability study Jen, Juif
 2013
 69-70 4 p. 114-119
6 p.
 artikel
248 Perspective: Proteomic approach to detect biomarkers of human growth hormone Ding, Juan
 2009
 69-70 4 p. 399-407
9 p.
 artikel
249 Pharmacokinetics of ipamorelin, a new GH secretagogue, after iontophoretic and intravenous administration to volunteers Green, P
 1998
 69-70 4 p. 332-
1 p.
 artikel
250 Pituitary cell transplantation in dwarf rats Robinson, ICAF
 1998
 69-70 4 p. 327-
1 p.
 artikel
251 Plasma disappearance rate of free insulinlike growth factor-I in healthy subjects Frystyk, J
 1998
 69-70 4 p. 314-315
2 p.
 artikel
252 Potential benefits of recombinant human growth hormone (rhGH) to athletes Graham, Michael R.
 2009
 69-70 4 p. 300-307
8 p.
 artikel
253 Progesterone modulates the effects of estrogen on IGFI in post-menopausal women Ho, KKY
 1998
 69-70 4 p. 316-
1 p.
 artikel
254 Program for the 1998 Growth Hormone Research Society Conference 1998
 69-70 4 p. 306-307
2 p.
 artikel
255 Protective effect of recombinant human somatotropin on amyloid β-peptide induced learning and memory deficits in mice Ling, Fu Ai
 2007
 69-70 4 p. 336-341
6 p.
 artikel
256 Randomized, double-blind, placebo-controlled trial of growth hormone in patients with dilated cardiomyopathy Osterziel, KJ
 1998
 69-70 4 p. 349-
1 p.
 artikel
257 Recombinant growth hormone has an anabolic effect on bone formation in distraction osteogenesis Raschke, M
 1998
 69-70 4 p. 335-336
2 p.
 artikel
258 Reduced retinal vascularization in children with growth hormone insufficiency Hellström, A
 1998
 69-70 4 p. 341-
1 p.
 artikel
259 Reference values of IGF-I in children from birth to 5 years of age, in Burkina Faso, using blood samples on filter paper Kouanda, S.
 2008
 69-70 4 p. 345-352
8 p.
 artikel
260 Regrowth of non-secreting pituitary adenoma and craniopharyngioma prior to GH-replacement therapy in KIMS Wilton, P
 1998
 69-70 4 p. 318-
1 p.
 artikel
261 Regulation of the GH/IGF axis in the denning black bear (Ursus Americanus) Unterman, TG
 1998
 69-70 4 p. 329-
1 p.
 artikel
262 Remission of Cushing's disease with growth hormone replacement Öztürk, Mustafa
 2011
 69-70 4 p. 238-241
4 p.
 artikel
263 Resting metabolic rate in healthy adults: Relation to growth hormone status and leptin levels Dall, R
 1998
 69-70 4 p. 351-
1 p.
 artikel
264 Revascularization and/or partially-maintained hypothalamic-pituitary portal system in patients with pituitary stalk transection Momoi, T
 1998
 69-70 4 p. 341-
1 p.
 artikel
265 Reversible dimerization of 20 kilodalton human growth hormone (hGH) Nagatomi, Y.
 2000
 69-70 4 p. 207-214
8 p.
 artikel
266 Reviewing the safety of GH replacement therapy in adults Stochholm, Kirstine
 2015
 69-70 4 p. 149-157
9 p.
 artikel
267 RHIGF-I administration increases in vivo peripheral insulin sensitivity in adults with type 1 diabetes mellitus Carroll, PV
 1998
 69-70 4 p. 315-
1 p.
 artikel
268 Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose Clemmons, D.R.
 2005
 69-70 4 p. 265-274
10 p.
 artikel
269 Role of the integrin αVβ3 in mediating increased smooth muscle cell responsiveness to IGF-I in response to hyperglycemic stress Clemmons, David R.
 2007
 69-70 4 p. 265-270
6 p.
 artikel
270 Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD) Chihara, K.
 2008
 69-70 4 p. 307-317
11 p.
 artikel
271 Safety aspects of longitudinal administration of IGF-I/IGFBP-3 complex in neonatal mice Hellgren, Gunnel
 2011
 69-70 4 p. 205-211
7 p.
 artikel
272 Secular trend in Israeli population and its effect on the ICP growth model of Karlberg (20 years of cross-sectional and longitudinal data) Zadik, Zvi
 1998
 69-70 4 p. 340-
1 p.
 artikel
273 Selective inner retinal dysfunction in growth hormone transgenic mice Martin, Brent T.
 2011
 69-70 4 p. 219-227
9 p.
 artikel
274 Serum acid-labile subunit levels in 31 patients with non-islet cell tumor hypoglycemia Hizuka, N
 1998
 69-70 4 p. 339-
1 p.
 artikel
275 Serum free insulin-like growth factor-I decreases during the night in healthy subjects and acromegalic patients but not in growth-hormone-deficient patients Skj˦rbr˦k, C
 1998
 69-70 4 p. 337-
1 p.
 artikel
276 Serum levels of insulin-like growth factor I and its binding proteins in health and disease Juul, Anders
 2003
 69-70 4 p. 113-170
58 p.
 artikel
277 Serum levels of the acid-labile subunit of the 150 KDA insulin-like growth factor binding protein complex: Impact of mode of growth hormone administration Laursen, T
 1998
 69-70 4 p. 339-
1 p.
 artikel
278 Severe growth hormone (GH) deficiency: One test VS two tests — The evidence Lissett, CA
 1998
 69-70 4 p. 344-345
2 p.
 artikel
279 Severe obstructive sleep apnoea syndrome in an adult patient with Laron syndrome Dagan, Yaron
 2001
 69-70 4 p. 247-249
3 p.
 artikel
280 Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor Meyer, S.
 2007
 69-70 4 p. 307-314
8 p.
 artikel
281 Short-term effects of growth hormone on bone metabolism in a patient with mild hunter disease Desenzani, P
 1998
 69-70 4 p. 343-
1 p.
 artikel
282 Short-term recombinant human growth hormone administration improves respiratory function in abstinent anabolic–androgenic steroid users Graham, Michael R.
 2007
 69-70 4 p. 328-335
8 p.
 artikel
283 Somatostatin analogs selective for sub-type 2 and 5 of the somatostatin receptor suppress with different patterns growth hormone (GH) secretion in human GH-secreting adenomas cultured in vitro Giustina, A
 1998
 69-70 4 p. 314-
1 p.
 artikel
284 Spatio-temporal kinetics of growth hormone receptor signaling in single cells using FRET microscopy Biener-Ramanujan, Eva
 2006
 69-70 4 p. 247-257
11 p.
 artikel
285 Statistical issues in implementing the marker method Bassett, E. Eryl
 2009
 69-70 4 p. 361-365
5 p.
 artikel
286 STAT 5 messenger RNA in normal and malnourished rats is upregulated by growth hormone treatment Ortiz, BL
 1998
 69-70 4 p. 322-
1 p.
 artikel
287 Strength of colonic anastomoses and skin incisional wounds in old rats — influence by diabetes and growth hormone Seyer-Hansen, M.
 1999
 69-70 4 p. 254-261
8 p.
 artikel
288 Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and non-peptide secretagogues Howard, AD
 1998
 69-70 4 p. 313-314
2 p.
 artikel
289 Surface plasmon resonance immuno assays – A perspective Gutiérrez-Gallego, R.
 2009
 69-70 4 p. 388-398
11 p.
 artikel
290 Sustained-release growth hormone in children and adults Kemp, SF
 1998
 69-70 4 p. 320-321
2 p.
 artikel
291 Systemic application of recombinant growth hormone increases the callus area in distraction osteogenesis Kolbeck, S
 1998
 69-70 4 p. 335-
1 p.
 artikel
292 The acid-labile subunit (ALS) of the 150 K complex in critically ill patients Barreca, A
 1998
 69-70 4 p. 339-340
2 p.
 artikel
293 The anabolic effect of recombinant growth hormoe (GH) on osteoblasts in distraction osteogenesis may be IGF-I mediated Bail, H
 1998
 69-70 4 p. 333-334
2 p.
 artikel
294 The Circulating IGF System in Hepatocellular Carcinoma: The Impact of Liver Status and Treatment Espelund, Ulrick
 2015
 69-70 4 p. 174-181
8 p.
 artikel
295 The correlation of the IGF-I, IGFBP-3, and ALS generation test to height velocity after 6 months of recombinant growth hormone therapy in girls with Turner syndrome Collett-Solberg, Paulo F.
 2006
 69-70 4 p. 240-246
7 p.
 artikel
296 The effect of a period of intensive exercise on the isoform test to detect growth hormone doping in sports Voss, S.C.
 2013
 69-70 4 p. 105-108
4 p.
 artikel
297 The effect of a physiological growth hormone pulse on lipolysis in abdominal and femoral adipose tissue assessed by microdialysis Gravholt, CH
 1998
 69-70 4 p. 325-
1 p.
 artikel
298 The effect of growth hormone treatment in idiopathic short stature with shox mutation Vaguin, P
 1998
 69-70 4 p. 320-
1 p.
 artikel
299 The effect of long-term growth hormone administration on the collagen concentration, relative amounts of type I and III collagen and pyridinoline collagen cross-links in rat hearts Bruel, A
 1998
 69-70 4 p. 328-
1 p.
 artikel
300 The effect of submaximal exercise on immuno- and bioassayable IGF-I activity in patients with GH-deficiency and healthy subjects Kanaley, J.A.
 2005
 69-70 4 p. 283-290
8 p.
 artikel
301 The effects of glutamine supplementation, GH and IGF-I on glutamine metabolism in the critically ILL Jackson, N
 1998
 69-70 4 p. 324-
1 p.
 artikel
302 The effects of 10 years of recombinant human growth hormone Healy, ML
 1998
 69-70 4 p. 349-
1 p.
 artikel
303 The effects of 10 years of recombinant human growth hormone Gibney, J
 1998
 69-70 4 p. 349-
1 p.
 artikel
304 The GH-receptor associates with Jak1, Jak2 and Tyk2 in human liver Hellgren, G
 1998
 69-70 4 p. 321-322
2 p.
 artikel
305 The growth-hormone IGF-I axis in patients with chronic heart failure and cachexia: GH resistance and lack of glucose-suppressibility of GH levels Pflaum, CD
 1998
 69-70 4 p. 326-327
2 p.
 artikel
306 The growth hormone receptor exon 3 polymorphism is not associated with height or metabolic traits in healthy young adults Martins, Clarissa S.
 2014
 69-70 4 p. 123-129
7 p.
 artikel
307 The growth hormone response to exercise and its relationship to menstrual cycle stage Hills, N
 1998
 69-70 4 p. 348-349
2 p.
 artikel
308 The history of doping and growth hormone abuse in sport Holt, Richard I.G.
 2009
 69-70 4 p. 320-326
7 p.
 artikel
309 The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes Hedman, Christina A.
 2005
 69-70 4 p. 304-310
7 p.
 artikel
310 The increase in muscle strength during rhgh therapy is due to an increase in muscle mass Janssen, YJH
 1998
 69-70 4 p. 318-
1 p.
 artikel
311 The insulin antagonistic effect of GH does not affect myocardial glucose uptake in healthy human subjects Botker, HE
 1998
 69-70 4 p. 327-
1 p.
 artikel
312 The insulin like growth factor-1 receptor (IGF-1R) as a drug target: novel approaches to cancer therapy Bähr, Corinna
 2004
 69-70 4 p. 287-295
9 p.
 artikel
313 The International Olympic Committee (IOC) and GH-2000 Sönksen, Peter
 2009
 69-70 4 p. 341-345
5 p.
 artikel
314 The metacarpal index in short stature before and during growth hormone therapy Bettendorf, M
 1998
 69-70 4 p. 342-
1 p.
 artikel
315 The modulation of cortisol metabolism by low-dose GH replacement in elderly hypopituitary patients Toogood, AA
 1998
 69-70 4 p. 324-
1 p.
 artikel
316 The pharmacokinetics, pharmacodynamics, safety and tolerability of a single dose of NN703, a novel orally active growth hormone secretagogue in healthy male volunteers Zdravkovic, M.
 2000
 69-70 4 p. 193-198
6 p.
 artikel
317 The physiology of growth hormone and sport Widdowson, W. Matthew
 2009
 69-70 4 p. 308-319
12 p.
 artikel
318 The psychology behind doping in sport Ehrnborg, Christer
 2009
 69-70 4 p. 285-287
3 p.
 artikel
319 Therapeutic applications of the insulin-like growth factors Savage, Martin O
 2004
 69-70 4 p. 301-308
8 p.
 artikel
320 The role of GH/IGF-I/cAMP/protein kinase a axis in the control of apoptosis and secretory activity of bovine ovarian granulosa cells Sirotkin, A
 1998
 69-70 4 p. 333-
1 p.
 artikel
321 The role of growth hormone (GH) and glucocorticoid (GC) in glucose intolerance and insulin resistance in vivo Johansen, T
 1998
 69-70 4 p. 352-
1 p.
 artikel
322 The role of suppressors of cytokine signaling (SOCS) in growth hormone (GH) receptor signaling Billestrup, N
 1998
 69-70 4 p. 322-
1 p.
 artikel
323 The total length of myocytes and capillaries, and total number of myocyte nuclei in the rat heart are time-dependently increased by growth hormone Brüel, Annemarie
 2005
 69-70 4 p. 256-264
9 p.
 artikel
324 The UK Sport perspective on detecting growth hormone abuse Stow, M.R.
 2009
 69-70 4 p. 375-377
3 p.
 artikel
325 5th International Workshop on IGF-Binding Proteins - Abstracts 2003
 69-70 4 p. 203-222
20 p.
 artikel
326 5th International Workshop on IGF-Binding Proteins - Index 2003
 69-70 4 p. 223-224
2 p.
 artikel
327 5th International Workshop on IGF-Binding Proteins - Meeting Programme 2003
 69-70 4 p. 193-202
10 p.
 artikel
328 Thyroid and growth hormone (GH)/insulin-like growth factor-I (IGF-I) axis: A clinical and utrasonographic study in patients with acromegaly and hypopituitarism Colao, A
 1998
 69-70 4 p. 350-
1 p.
 artikel
329 Tissue-specific regulation of IGF-I and IGF-binding proteins in response to TNFα Lang, Charles H.
 2001
 69-70 4 p. 250-260
11 p.
 artikel
330 Transcriptional and epigenetic control of IGF1R gene expression: Implications in metabolism and cancer Werner, Haim
 2014
 69-70 4 p. 112-118
7 p.
 artikel
331 Transgenic mice expressing selected insulin-like growth factor-binding protein-5 fragments do not exhibit enhanced bone formation Durant, D
 2004
 69-70 4 p. 319-327
9 p.
 artikel
332 Treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 does not increase lipoprotein(A) concentrations Svensson, J
 1998
 69-70 4 p. 333-
1 p.
 artikel
333 Treatment with recombinant human growth hormone of children with meningomyelocele and growth hormone deficiency: 2-year results Hochhaus, F
 1998
 69-70 4 p. 320-
1 p.
 artikel
334 Unaltered ratio of circulating levels of growth hormone/GH isoforms in adults with Prader–Willi syndrome after GHRH plus arginine administration Rigamonti, A.E.
 2015
 69-70 4 p. 168-173
6 p.
 artikel
335 10 years of experience in the growth hormone treatment of adult GH deficiency Russell-Jones, DL
 1998
 69-70 4 p. 311-
1 p.
 artikel
                             335 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland